| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999004007A8 Increasing production of proteins in gram-positive microorganisms |
| 04/22/1999 | WO1999002693A3 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins |
| 04/22/1999 | WO1999001565A9 Method for increasing secretion of proteins in eukaryotic host cells |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998047921A9 Mammalian cytokines; related reagents and methods |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | CA2745783A1 .alpha.-amylase mutants |
| 04/22/1999 | CA2696653A1 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2306697A1 Low ph lactic acid fermentation |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306207A1 Geranyl diphosphate synthase from mint (mentha piperita) |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305574A1 Competitive exclusion culture for swine |
| 04/22/1999 | CA2303844A1 Regulators of ucp3 gene expression |
| 04/22/1999 | CA2275135A1 Phosphodiesterase 8a |
| 04/21/1999 | EP0909821A2 Engineering enzymes having altered substrate specificity |
| 04/21/1999 | EP0909817A1 Uses of gro genes and proteins |
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909331A1 System for detecting protein-protein interactions |
| 04/21/1999 | EP0909329A1 Method of control of haematococcus spp. growth process |
| 04/21/1999 | EP0909327A2 Erythromycins and process for their preparation |
| 04/21/1999 | EP0909324A2 Toxins active against pests |
| 04/21/1999 | EP0909323A1 Helicobacter pylori bacterioferritin |
| 04/21/1999 | EP0909321A2 Mammalian chemokine reagents |
| 04/21/1999 | EP0909319A2 Growth arrest gene compositions and methods |
| 04/21/1999 | EP0909318A1 Human stem cell antigens, dna coding therefor and their use |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909312A1 Method for the production of polypeptides |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909273A1 A transcription factor |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214732A Novel 'beta'-l-4N-acetylglucosaminyltransferase and gene encoding the same |
| 04/21/1999 | CN1214731A Alkaline protease deficient filamentous fungi |
| 04/21/1999 | CN1214693A Novel protein |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/21/1999 | CN1214366A Method for producing optically active compound |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895813 Diagnosis and treatment of TKA-1 related disorders |
| 04/20/1999 | US5895758 Pure culture; for antitumor agents, viricides; nutritional supplements |
| 04/20/1999 | US5895757 Encapsulation of living tissue cells in inorganic microspheres prepared from an organosilicon |
| 04/20/1999 | US5895755 Platelet derived growth factor |
| 04/20/1999 | US5895671 Cheese culture medium and method for preparing no fat and low fat cheese products |
| 04/20/1999 | US5895654 Streptococcus equi vaccine |
| 04/20/1999 | US5895648 Two species of bacteria, oligosaccharides dispersed in ingestible natural product |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/20/1999 | CA1340505C Bovine placental lactogen |
| 04/20/1999 | CA1340504C Y-glutamyltranspeptidase, its preparation and its use |
| 04/15/1999 | WO1999018239A1 Antimicrobial drug screening using a recombinant cell comprising a rna-dependent amidotransferase gene |
| 04/15/1999 | WO1999018229A1 A process for the biotransformation of colchicone compounds into the corresponding 3-glycosyl derivatives |
| 04/15/1999 | WO1999018228A2 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018224A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018219A1 A keratinocyte derived protease |
| 04/15/1999 | WO1999018218A1 Alkaline protease |
| 04/15/1999 | WO1999018212A1 Natural human antibody |
| 04/15/1999 | WO1999018211A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 04/15/1999 | WO1999018207A1 Human hox c10 and polynucleotides encoding |
| 04/15/1999 | WO1999018201A1 Gankyrin |
| 04/15/1999 | WO1999018196A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 04/15/1999 | WO1999018188A1 Feed product |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018122A1 Ama |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018037A1 A method of preparing a microbial culture for wastewater treatment |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999007738A3 Human orphan receptor ntr-1 |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999004016A3 Proteases from gram-positive organisms |
| 04/15/1999 | WO1999003872A9 Nucleic acid ladders |
| 04/15/1999 | WO1998059058A3 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19831609A1 Increasing microbial production of specific amino acids by increasing activity or expression of pyruvate carboxylase |
| 04/15/1999 | DE19821060A1 Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung Co-stimulatory polypeptide of T-cells, monoclonal antibodies and the production and use thereof |
| 04/15/1999 | DE19744212A1 Verfahren zur Herstellung von Ergosterol und dessen Zwischenstufen mittels rekombinanter Hefen A process for producing ergosterol and its intermediates by recombinant yeasts |
| 04/15/1999 | CA2309791A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2305814A1 Gankyrin |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305712A1 Natural humanized antibody |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305708A1 A keratinocyte derived protease |
| 04/15/1999 | CA2305577A1 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 04/15/1999 | CA2305559A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |